Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027)

Clinical trial NCT01106287 · COMPLETED

Trial details

NCT number: NCT01106287
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2009-10-01
Primary completion: 2010-01-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.